Design Therapeutics, Inc. announced the initiation of a Phase 1 clinical trial for its gene-targeted treatment DT-216P2 in healthy volunteers, with patient dosing for Friedreich Ataxia (FA) set to ...

Relay Therapeutics (NasdaqGM:RLAY) plans to move its lead program, zovegalisib, into Phase 3 development for frontline PI3Ka ...

Moderna has finalized the design and dosage of its phase 3 COVID-19 vaccine trial, keeping it on track to start the pivotal test next month. Work to get the 30,000-subject phase 3 trial underway is ...

Phase II study of dalantercept, a novel inhibitor of ALK1-mediated angiogenesis, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Background: Clinical trial ...

Midjourney, the well-known AI art generation system and independent research lab, has announced the rollout of phase 1 of its new website design making it available on a beta subdomain for users to ...

The Accelsius study, with analysis by Jacobs, indicates that two-phase direct-to-chip liquid cooling may offer up to 35% lower OpEx and 12% lower TCO compared to single-phase approaches Adoption of ...

Chemomab Therapeutics has announced that it has successfully completed its End-of-Phase 2 meeting with the FDA, aligning on the design of a single Phase 3 trial for its lead product candidate, ...

Detroit Arsenal, Mich. (Dec. 9, 2020) - Today, the U.S. Army conducted a virtual Industry Day for the Optionally Manned Fighting Vehicle (OMFV) program to provide an overview of the program’s ...

Construction isn’t getting cheaper, and demand for space isn’t getting smaller. Architecture 2030 projects the world will add 2.6 trillion square feet of new floor space between 2020 and 2060. Not ...